Nxera Pharma Co., Ltd. (TYO:4565)
Japan flag Japan · Delayed Price · Currency is JPY
868.00
-11.00 (-1.25%)
Aug 6, 2026, 11:30 AM JST

Nxera Pharma Cash Flow Statement

Millions JPY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-9,977-14,950-4,662-10,6801,078433
Depreciation & Amortization
4,3854,3663,9842,4781,3451,278
Loss (Gain) From Sale of Assets
-1,160---3,138
Loss (Gain) From Sale of Investments
--51,3631,877-208
Loss (Gain) on Equity Investments
57---429-50
Other Operating Activities
6,4121,45028-942338486
Change in Accounts Receivable
-7,072-1,039-7421,315-210-799
Change in Inventory
-2,395-2,456-5,9351,908--
Change in Accounts Payable
2462,971-4871,552315-184
Change in Other Net Operating Assets
8855,83091-2,2674,7803,001
Operating Cash Flow
-4,935-2,668-7,718-5,2739,9527,095
Operating Cash Flow Growth
----40.27%51.86%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-643-448-526-804-277-193
Cash Acquisitions
----62,941--
Divestitures
-----206
Sale (Purchase) of Intangibles
-5,043-177-1,011-47-26-8
Investment in Securities
2,0496,028-3,870-1,209-
Other Investing Activities
9276441137273
Investing Cash Flow
-3,6285,430-4,763-63,7911,043278

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---71,608-29,855
Long-Term Debt Repaid
--15,139-5,800-1,450--
Total Debt Repaid
-16,021-15,139-5,800-1,450--
Net Debt Issued (Repaid)
-16,021-15,139-5,80070,158-29,855
Issuance of Common Stock
---9,983-600
Other Financing Activities
-6-889-1,054-31,812-4,887-19,332
Financing Cash Flow
-16,027-16,028-6,85448,329-4,88711,123

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1,7221,3622,5383,2433621,583
Miscellaneous Cash Flow Adjustments
1-----
Net Cash Flow
-22,867-11,904-16,797-17,4926,47020,079

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-5,578-3,116-8,244-6,0779,6756,902
Free Cash Flow Growth
----40.18%50.70%
Free Cash Flow Margin
-16.30%-10.52%-28.59%-47.60%62.14%38.97%
Free Cash Flow Per Share
-61.69-34.52-91.87-73.65117.1484.17
Levered Free Cash Flow
-13,823-2,529-9,249-11,530-1,3678,544
Unlevered Free Cash Flow
-9,128-2,001-8,768-11,038-946.58,868

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
601531435241171157
Cash Income Tax Paid
245-1,0072691,394262-87
Change in Working Capital
-9,2645,306-7,0732,5084,8852,018